Mali’s innovative use of the R21/Matrix-M vaccine in Kayes and Mopti
Mali is reaching a pivotal moment in its fight against malaria. By implementing the WHO-endorsed R21/Matrix-M vaccine, the regions of Kayes and Mopti are pioneering a fresh immunization approach. This medical shield, combining seasonal delivery with careful monitoring, is now safeguarding thousands of Malian children.Demonstrating its commitment to public health, Mali has integrated the R21/Matrix-M malaria vaccine into its Expanded Programme on Immunization (EPI). Supported by international partners like Gavi, UNICEF, and the WHO, this rollout focuses on 19 priority districts across five regions, with Kayes and Mopti leading the way through advanced methodology.The "hybrid" strategy: A precision health toolMoving beyond traditional vaccination methods, Mali has adopted a hybrid model. Thi...











